Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Share :

13th Congress of the EADO

3 - 6 May 2017
Megaron Athens International Conference Centre, Athens, Greece

EADO conference highlights

Will Davies - Medical Reporter, ecancer
EADO conference highlights ( Will Davies - Medical Reporter, ecancer )
23 May 2017

Theory and application of electrochemotherapy

Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy
Theory and application of electrochemotherapy ( Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy )
23 May 2017

Intralesional T-VEC and combinations for melanoma

Prof Sanjiv Agarwala - St. Luke's Cancer Center, Easton, USA
Intralesional T-VEC and combinations for melanoma ( Prof Sanjiv Agarwala - St. Luke's Cancer Center, Easton, USA )
18 May 2017

Role of histologic regression in melanoma

Dr Simone Ribero - Università degli Studi di Torino, Turin, Italy
Role of histologic regression in melanoma ( Dr Simone Ribero - Università degli Studi di Torino, Turin, Italy )
18 May 2017

Molecular testing for targeted therapies

Prof Claus Garbe - University of Tübingen, Tübingen, Germany
Molecular testing for targeted therapies ( Prof Claus Garbe - University of Tübingen, Tübingen, Germany )
18 May 2017

Brain metastases: Gamma knife and new treatments

Dr Jean Jacques Grob - Hôpital de la Timone, Marseille, France
Brain metastases: Gamma knife and new treatments ( Dr Jean Jacques Grob - Hôpital de la Timone, Marseille, France )
18 May 2017

Essential regional control of skin cancers

Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy
Essential regional control of skin cancers ( Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy )
18 May 2017

Update in anti-CTLA4 and anti-PD1 treatment in advanced melanoma

Dr Christian Blank - Netherlands Cancer Institute, Amsterdam, The Netherlands
Update in anti-CTLA4 and anti-PD1 treatment in advanced melanoma ( Dr Christian Blank - Netherlands Cancer Institute, Amsterdam, The Netherlands )
18 May 2017

Circulating tumour cells in melanoma

Dr Evi Lianidou - University of Athens, Athens, Greece
Circulating tumour cells in melanoma ( Dr Evi Lianidou - University of Athens, Athens, Greece )
18 May 2017

Novel high risk genes of melanoma

Prof Nick Hayward - QIMR Berghofer, Brisbane, Australia
Novel high risk genes of melanoma ( Prof Nick Hayward - QIMR Berghofer, Brisbane, Australia )
18 May 2017

New insights in Merkel cell biology and treatment

Dr Paul Nghiem - University of Washington, Seattle, USA
New insights in Merkel cell biology and treatment ( Dr Paul Nghiem - University of Washington, Seattle, USA )
18 May 2017

Duration of checkpoint inhibitor therapy

Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany
Duration of checkpoint inhibitor therapy ( Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany )
17 May 2017

PD1/ CTLA4 : Upfront or sequentially?

Prof Christoph Höller - Medical University of Vienna, Vienna, Austria
PD1/ CTLA4 : Upfront or sequentially? ( Prof Christoph Höller - Medical University of Vienna, Vienna, Austria )
17 May 2017

Brain metastases: a role of conventional chemotherapy?

Dr Peter Mohr - Elbe Klinikum Buxtehude, Germany
Brain metastases: a role of conventional chemotherapy? ( Dr Peter Mohr - Elbe Klinikum Buxtehude, Germany )
17 May 2017

New imaging approaches for the diagnosis of melanoma and skin cancer

Dr Josep Malvehy - University Hospital Clinic of Barcelona, Barcelona, Spain
New imaging approaches for the diagnosis of melanoma and skin cancer ( Dr Josep Malvehy - University Hospital Clinic of Barcelona, Barcelona, Spain )
17 May 2017